Accountable Care Organizations Still Play a Vital Role in Value-Based Care
Moving away from accountable care organizations (ACOs) will not lead to value-based care, according to Luke Hansen, M.D., M.H.S., and chief medical officer of Arcadia, a healthcare data analytics company.
Accountable care organizations (ACOs) still play an important role in value-based care, and shifting away from them at this time would be a mistake, according to Luke Hansen, M.D., M.H.S. In a video interview with Managed Healthcare Executive, Hansen explained why ACOs are still important.
Luke Hansen, M.D., M.H.S.
“Bundled programs are a necessary piece,” Hansen said. “The ACO structure can transfer accountability for cost to PCPs [primary care physicians], but at the end of the day, if you play that out and you really start to tighten the screws, I worry we end up back where we were with managed care 1.0, where the PCPs become gatekeepers.”
Hansen went on to explain that thoughtfully transferring risk to organizations is the key to success.
“If we were to just transfer risk, in a thoughtful way, to an organization to get them to think more about a population attribution than clinic visit volume—that's the key component of the program that's needed,” Hansen continued. “Right now, there are still the engines, the machines, of the provider industry attuned to visits, which are inherently reactive. If we could figure out a way to give accountability for populations to these organizations, they could reverse engineer how to get to those people and bring them in appropriately.”
United Health Foundation Awards $7M in Grants to Improve Maternal, Infant Health
April 9th 2025United Health Foundation, the charitable branch of UnitedHealth Group, awarded more than $7 million in grants to organizations in Georgia, Michigan, New Mexico and Wisconsin to improve maternal and infant healthcare, reduce disparities and strengthen the doula workforce in underserved communities.
Read More
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
Rutgers Cancer Institute Reviews Guidelines for Managing Blood Cancers During Pregnancy
April 8th 2025About 6% of pregnancy-related cancers are Hodgkin lymphoma, and 5% are non-Hodgkin lymphoma. Leukemias in pregnancy are rarer, accounting for 1 in 10,000 pregnancies. The most common pregnancy-related leukemias are acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), and chronic myeloid leukemia (CML).
Read More
